Results 301 to 310 of about 850,017 (337)
Some of the next articles are maybe not open access.

Inactivated and Adjuvanted Influenza Vaccines

Current Topics in Microbiology and Immunology, 2014
Inactivated influenza vaccines are produced every year to fight against the seasonal epidemics of influenza. Despite the nonoptimal coverage, even in subjects at risk like the elderly, pregnant women, etc., these vaccines significantly reduce the burden of mortality and morbidity linked to the influenza infection.
Giuseppe, Del Giudice, Rino, Rappuoli
openaire   +3 more sources

Whole Inactivated Virus and Protein-Based COVID-19 Vaccines.

Annual Review of Medicine, 2021
The rapid development and deployment of mRNA and adenovirus-vectored vaccines against coronavirus disease 2019 (COVID-19) continue to astound the global scientific community, but these vaccine platforms and production approaches have still not achieved ...
P. Hotez, M. Bottazzi
semanticscholar   +1 more source

COVID-19 vaccines

Current Opinion in Immunology, 2021
COVID-19 is a pandemic of unprecedented proportions in recent human history. Less than 18 months since the onset of the pandemic, there are close to two hundred million confirmed cases and four million deaths worldwide.
D. Ndwandwe, C. Wiysonge
semanticscholar   +1 more source

An inactivated vaccine against ringworm

Comparative Immunology, Microbiology and Infectious Diseases, 1992
A new vaccine against ringworm, containing the inactivated Trichophyton verrucosum strain, was assessed on guinea pigs and calves under experimental conditions and on three herds of cattle under natural conditions. The vaccine elicited a distinct immune response of the cellular type.
K, Wawrzkiewicz, J, Wawrzkiewicz
openaire   +2 more sources

Inactivated virosome hepatitis A vaccine

The Lancet, 1994
Immunopotentiating reconstituted influenza virosomes (IRIV) are efficient carrier systems for small virion particles such as hepatitis A virus (HAV). We evaluated immunogenicity and tolerability of an IRIV-HAV vaccine and the effectiveness of a booster by immunising 104 healthy HAV seronegative volunteers. A single dose was highly immunogenic, since 98%
L, Loutan   +3 more
openaire   +2 more sources

Inactivated Poliovirus Vaccine

Human Vaccines, 2007
Subhash C, Arya, Nirmala, Agarwal
openaire   +2 more sources

Polio Vaccines— Live or Inactivated?

JAMA: The Journal of the American Medical Association, 1966
To the Editor:— Two excellent vaccines are in current use to protect against poliomyelitis. Inactivated poliomyelitis vaccine (IPV) developed by Salk has been widely used since 1955. IPV is characterized by complete safety, imperfect immunizing power, and the need for percutaneous administration.
openaire   +2 more sources

Inactivated newcastle disease vaccine

Journal of Comparative Pathology and Therapeutics, 1963
S A, KEEBLE, J A, WADE
openaire   +2 more sources

Home - About - Disclaimer - Privacy